PHR (Phreesia) Piotroski F-Score: 5 (As of Jun. 25, 2026) — 25% Above Median


PHR Phreesia Inc PHR
65 GF Score
Price $9.59
GF Value $26.97
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Phreesia Piotroski F-Score?

Phreesia PHR +4.81% 65 Piotroski F-Score is 5 as of Jun. 25, 2026, which is 25% above its 10-year median of 4.00. GuruFocus rates PHR with a GF Score™ of 65/100 and a GF Value™ of $26.97 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Phreesia ranks better than 54.38% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Phreesia has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Phreesia's Piotroski F-Score or its related term are showing as below:

PHR' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 7
Current: 5

During the past 9 years, the highest Piotroski F-Score of Phreesia was 7. The lowest was 2. And the median was 4.

Phreesia  (NYSE:PHR) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Phreesia Piotroski F-Score Related Terms


Phreesia Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Phreesia's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phreesia Piotroski F-Score Chart

Phreesia Annual Data
Trend Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 3.00 3.00 3.00 6.00 6.00

Phreesia Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 7.00 6.00 5.00

PHR vs HSTM, WEAV, EVH: Piotroski F-Score Comparison

For the Health Information Services subindustry, Phreesia's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phreesia Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Phreesia's Piotroski F-Score falls into.


PHR
65GF Score
Phreesia Inc PHR
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Apr26) TTM:Last Year (Apr25) TTM:
Net Income was 0.654 + 4.271 + 1.295 + 2.963 = $9.2 Mil.
Cash Flow from Operations was 14.835 + 15.467 + 33.662 + 23.922 = $87.9 Mil.
Revenue was 117.255 + 120.333 + 127.067 + 130.935 = $495.6 Mil.
Gross Profit was 79.614 + 82.306 + 86.677 + 87.601 = $336.2 Mil.
Average Total Assets from the begining of this year (Apr25)
to the end of this year (Apr26) was
(400.395 + 408.629 + 423.472 + 663.79 + 666.141) / 5 = $512.4854 Mil.
Total Assets at the begining of this year (Apr25) was $400.4 Mil.
Long-Term Debt & Capital Lease Obligation was $86.2 Mil.
Total Current Assets was $267.3 Mil.
Total Current Liabilities was $152.1 Mil.
Net Income was -18.012 + -14.403 + -6.39 + -3.914 = $-42.7 Mil.

Revenue was 102.115 + 106.8 + 109.681 + 115.936 = $434.5 Mil.
Gross Profit was 69.304 + 72.263 + 76.115 + 77.871 = $295.6 Mil.
Average Total Assets from the begining of last year (Apr24)
to the end of last year (Apr25) was
(372.086 + 362.235 + 375.703 + 388.415 + 400.395) / 5 = $379.7668 Mil.
Total Assets at the begining of last year (Apr24) was $372.1 Mil.
Long-Term Debt & Capital Lease Obligation was $6.6 Mil.
Total Current Assets was $215.4 Mil.
Total Current Liabilities was $110.7 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Phreesia's current Net Income (TTM) was 9.2. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Phreesia's current Cash Flow from Operations (TTM) was 87.9. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Apr25)
=9.183/400.395
=0.02293485

ROA (Last Year)=Net Income/Total Assets (Apr24)
=-42.719/372.086
=-0.11480948

Phreesia's return on assets of this year was 0.02293485. Phreesia's return on assets of last year was -0.11480948. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Phreesia's current Net Income (TTM) was 9.2. Phreesia's current Cash Flow from Operations (TTM) was 87.9. ==> 87.9 > 9.2 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Apr26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Apr25 to Apr26
=86.194/512.4854
=0.16818821

Gearing (Last Year: Apr25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Apr24 to Apr25
=6.563/379.7668
=0.01728166

Phreesia's gearing of this year was 0.16818821. Phreesia's gearing of last year was 0.01728166. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Apr26)=Total Current Assets/Total Current Liabilities
=267.261/152.109
=1.75703607

Current Ratio (Last Year: Apr25)=Total Current Assets/Total Current Liabilities
=215.409/110.72
=1.94552926

Phreesia's current ratio of this year was 1.75703607. Phreesia's current ratio of last year was 1.94552926. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Phreesia's number of shares in issue this year was 62.041. Phreesia's number of shares in issue last year was 58.921. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=336.198/495.59
=0.67837931

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=295.553/434.532
=0.68016395

Phreesia's gross margin of this year was 0.67837931. Phreesia's gross margin of last year was 0.68016395. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Apr25)
=495.59/400.395
=1.23775272

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Apr24)
=434.532/372.086
=1.16782679

Phreesia's asset turnover of this year was 1.23775272. Phreesia's asset turnover of last year was 1.16782679. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Phreesia has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Phreesia (PHR) has a Piotroski F-Score of 5 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Phreesia and its competitors. This is 25% above median its historical median of 4.00. Over the past decade, Phreesia's Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Phreesia ranks #297 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 45.6%.
Is Phreesia's Piotroski F-Score too high?
Phreesia's current Piotroski F-Score of 5 is 25% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Phreesia's value of 5 is 0% at this industry median. Based on the distribution chart, Phreesia ranks #297 out of 651 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's Piotroski F-Score compare to HSTM and WEAV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #297 out of 651 companies for Piotroski F-Score. This puts Phreesia in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Phreesia's value of 5 is 0% at this benchmark. Historically, Phreesia's own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Phreesia has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phreesia's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current Piotroski F-Score is 5, which is 25% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (PHR) is currently considered Possible Value Trap. The stock's GF Value™ is $26.97, compared to a current price of $9.59 — trading 64.4% below its estimated fair value. The current Piotroski F-Score is 5, which is 25% above median its 10-year median of 4.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Phreesia's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Phreesia (PHR), the current Piotroski F-Score is 5 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phreesia (PHR) Overvalued in 2026?

Based on GuruFocus' analysis, Phreesia stock appears to be undervalued. The current stock price of $9.59 is trading 64.4% below its estimated GF Value™ of $26.97. GuruFocus considers Phreesia to be Possible Value Trap.

Key valuation signals for PHR:

  • Piotroski F-Score: 5 (25% above median its 10-year median of 4.00)
  • GF Value™: $26.97 vs. price of $9.59 (64.4% below fair value)
  • GF Score™: 65/100 with 3 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#297 of 651)

No single metric tells the full story. See the PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phreesia Business Description

Other Exchanges 19P:Germany
Address 1521 Concord Pike, Suite 301, PMB 221, Wilmington, DE, USA, 19803
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score

Get the complete analysis for PHR

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.59
Price
$26.97
GF Value